Introduction {#Sec1}
============

Large anterior mediastinal mass causing compression on vital structures like trachea, superior vena cava, pulmonary artery, right atrium, etc. is always challenging to manage. When indicated, surgical removal of such masses often requires mechanical circulatory support in the form of cardiopulmonary bypass or extracorporeal membrane oxygenation (ECMO). However, a large proportion of these tumors are lymphoma and leukemia, for which chemotherapy or cytolytic therapy is very effective. While undergoing or waiting for cytolytic therapy, these patients are at significant risk of sudden cardiorespiratory collapse because of critical compression of vital structures. We report a similar case here.

Case report {#Sec2}
===========

A 21-year-old female was referred to our hospital with complaints of rapidly progressing shortness of breath and recent onset of dysphagia to solid food for the last 1 month. She had also noted progressive swelling of her face, hands, and lower extremities over the past few weeks. Her past medical history was significant for tonsillectomy and bronchial asthma, for which she was taking albuterol inhaler occasionally. She was an inconsistent smoker, not more than half a pack/day, for the last 2 years and was undergoing deaddiction treatment with nicotine patch. Computed tomography (CT) angiogram showed a large anterior mediastinal soft tissue mass causing rightward deviation and compression of the trachea and esophagus, partial collapse of left upper and lower lobes, and large left pleural effusion (Fig. [1a](#Fig1){ref-type="fig"}). The mass was also found to be causing compression on the main pulmonary artery and right ventricular outflow tract (Fig. [1b](#Fig1){ref-type="fig"}). CT also revealed extensive retrocrural and periaortic lymphadenopathy. Left thoracostomy tube drained a liter of straw-colored fluid. Cytology from pleural fluid showed abundant intermediate-sized lymphocytes, without Reed-Sternberg cells. CT-guided biopsy showed T cell lymphoblastic lymphoma. Baseline lactate dehydrogenase was 641 units/L with normal ß-hCG levels.Fig. 1**a** Large anterior mediastinal mass compressing pulmonary artery and right ventricular outflow tract (three white arrows). **b** Coronal view of the mass. **c** Right pulmonary artery thrombus (white arrow). **d** Left inferior pulmonary artery thrombus (white arrow)

Four hours after CT-guided biopsy, the patient had a syncopal attack followed by sudden increase in breathlessness. Electrocardiogram showed sinus tachycardia, and pulse oximetry showed profound hypoxia. She was immediately transferred to the Intensive Care Unit and was intubated. Despite intubation, ventilator optimization, and bronchodilators, she remained persistently hypoxic. Arterial blood gas showed metabolic acidosis (pH 7.29, pO2 59 mmHg and pCO2 38 mmHg, base deficit of 8) with 100% FiO2 on ventilator with optimum pressure-volume settings (tidal volume of 480 ml and positive end expiratory pressure of 10 cm of water) and complete muscle paralysis. At this point, only minimal dose of vasopressin was required to support mean arterial blood pressure (which was 75 mmHg), but extremities were cold, and arterial blood gas suggested high possibility of low cardiac output. On clinical examination, central venous pressure was very high and was estimated to be above 15 cm of water.

Two major differential diagnoses were tabled: (1) acute sub-massive pulmonary embolus (PE) and (2) post-biopsy hemorrhage inside the tumor leading to sudden enlargement of mass and compression on the heart. A quick bedside screening transthoracic echocardiography (TTE) showed normal sized left and right ventricle (RV) with good contractility but with partial RV outflow tract obstruction. A large mass was clearly visible anterior to the pericardium. Bedside emergent chest X-Ray did not show any significant increase in the mass size. She was considered unstable for emergency CT scan.

Since she only needed minimal vasopressin and screening echocardiography looked relatively unremarkable, discussion took place for choice of ECMO---veno-venous vs veno-arterial. Potential cardiac compression (as reflected by high jugular pressure), suspicion of sub-massive PE, cold extremities, clinical suspicion of low cardiac output, and worsening metabolic acidosis were major determining factors behind our decision of emergent VA ECMO. Peripheral VA ECMO comes with a caveat of limb ischemia risk, but she was young and had no history of peripheral vascular disease. Therefore, VA ECMO was established in percutaneous fashion using groin vessels. A 6F distal perfusion catheter was placed and connected to ECMO circuit to avoid limb ischemia.

After stabilization, detailed bedside TTE showed large mass anterior to pericardium causing significant compression of RV and RV outflow tract, albeit on ECMO with fully drained RV (Videos [1](#MOESM1){ref-type="media"} and [2](#MOESM2){ref-type="media"}). After initiation of ECMO, arterial blood gas showed pH 7.34, pO2 107 mmHg, pCO2 37 mmHg, and base deficit of 5 on ECMO flow of 4.8 L and sweep gas of 4 L.

Video 1Transthoracic echocardiography showing large anterior mediastinal mass compressing pulmonary artery and right ventricular outflow tract (after ECMO) (MOV 2058 kb) (MOV 2058 kb) Video 2Transthoracic echocardiography showing large anterior mediastinal mass compressing right ventricle (after ECMO) (MOV 2161 kb) (MOV 2161 kb)

CT angiogram showed new finding of right pulmonary artery and left lower lobar artery thrombus (Fig. [1c, d](#Fig1){ref-type="fig"}) and ruled out hemorrhage in the mass. Intravenous heparin infusion was started and titrated with target activated prothrombin time of 60--70 s. Retrospectively thinking, compression caused by mass prevented RV dilation and caused tamponade physiology, completely masking the usual echocardiographic picture of acute PE.

Dexamethasone as a cytoreductive agent along with allopurinol and rasburicase, to prevent tumor lysis syndrome, was started as per hematology recommendation. In a multidisciplinary meeting, it was decided that surgical debulking was inappropriate from hematological point of view and was reserved as a last resort. So it was decided to use VA ECMO as a bridge to interventional suction thrombectomy and cytoreductive therapy.

Next day, she underwent a successful suction thrombectomy in intervention radiology suit using a FlowTriever device (Inari Medical) through right internal jugular vein, under ECMO support.

Within a day after initiation of the cytoreductive therapy, lactate dehydrogenase level jumped beyond 1000 units/L within 24 h suggesting rapid tumor cell lysis. Two days after initiation of cytoreductive therapy, bedside TTE showed significant hemodynamic relief with reduction in mass size sitting anterior to pericardium (Video [3](#MOESM3){ref-type="media"}). ECMO weaning ramp study was found to be encouraging. Next day, after total 3 days of uncomplicated ECMO support, she was successfully weaned off ECMO and decannulated in the operating room with direct surgical repair of femoral artery. Further cytoreductive chemotherapy was well tolerated during the hospital course. Two days after decannulation, she was transferred to another hospital, specialized in hematological malignancies and chemotherapy, with minimal ventilator support.

Video 3Transthoracic echocardiography showing reduced size of anterior mediastinal mass with no hemodynamic compression of right ventricle (MOV 2022 kb) (MOV 2022 kb)

Discussion {#Sec3}
==========

The need for emergency ECMO for cardiorespiratory compromise in mediastinal malignancy is uncommon. There are few case reports in the literature which describe airway and vena caval compression by mediastinal mass requiring ECMO \[[@CR1]--[@CR3]\]. Our case report is a unique combination of large mediastinal mass with pulmonary artery and RV outflow tract compression complicated by acute sub-massive pulmonary embolism causing cardiorespiratory collapse. PubMed search using MESH words "Mediastinal Neoplasms" AND "Extracorporeal Membrane Oxygenation" AND "Pulmonary Embolism" showed 0 results. Scopus and Google Scholar search using the same words did not reveal any report similar to ours.

Given the screening echocardiography findings, we did not hesitate to proceed with VA ECMO considering potential compression, sub-massive PE suspicion, and metabolic acidosis. In otherwise healthy young individuals without any underlying cardiac disease or sepsis, sinking blood pressure is usually the last sign of low cardiac output. It is very important to identify low cardiac output earlier in the clinical course and treat appropriately, in our case using ECMO, to prevent end organ ischemia.

In conclusion, presence of large anterior mediastinal mass may mask echocardiographic signs of acute PE, and critical decisions must rely on clinical judgment. VA ECMO can be used as a bridge to cytoreductive therapy in presence of hemodynamic compromise.
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